Prestige Consumer Healthcare Inc.

NYSE:PBH

Medical - Distribution

Healthcare
$50.62 +0.49%

+$0.23 today

Market cap
$2.40B
Beta
0.35
P/E (TTM)
11.6
EPS (TTM)
$4.01
52W Low $42.62High $85.29

Volume 0.62M

Average 0.67M

PBH EBITDA Margin

EBITDA as a percentage of revenue.

Prestige Consumer Healthcare Inc.NYSE: PBH

EBITDA Margin · Q1 FY2027 · quarter ended Jun 2026

EBITDA Margin narrows to 23.0%

EBITDA Margin was 23.0% in Q1 FY2027, down 8.9 pp from a year earlier. On a trailing-twelve-month basis it was 28.3%, down 4.0 pp year over year. Over 3 fiscal years it widened by 29.7 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 28.1% for the fiscal year ending Mar 2027, down from 30.4% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
23.0%-7.0 pp QoQ
Last fiscal yearMar 2026
30.4%-1.4 pp YoY
LTMJun 2026
28.3%-4.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.9 pp+0.9 pp+9.8 pp
1 year-1.4 pp-2.3 pp-0.9 pp
3 years+29.7 pp-1.3 pp-31.0 pp
5 years+0.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
30.4%
Year-over-year change
-1.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How PBH compares with its peers on the latest reported figures

  • PBH's LTM Jun 2026 EBITDA Margin of 28.3% is the 2nd highest of the 10 companies compared; the peer median is 7.3%.
  • Its year-over-year change of -4.0 pp is the lowest of 10, against a peer median of +8.0 pp.
  • Over three fiscal years its change of +29.7 pp compares with a peer median of +5.3 pp.
PBH Competitors Peer median
EBITDA Margin for PBH and competitors
Company Period LTM level YoY 3-year change
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 202656.1% +0.7 pp+5.1 pp
PBHPrestige Consumer Healthcare Inc.LTM Jun 202628.3% -4.0 pp+29.7 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202620.5% +1.3 pp-0.2 pp
LIVNLivaNova PLCLTM Sep 202614.0% +20.0 pp-12.4 pp
ICUIICU Medical, Inc.LTM Jun 202611.5% -2.1 pp+5.5 pp
LEGNLegend Biotech CorporationLTM Sep 20267.3% +27.5 pp+333.4 pp
PRVAPrivia Health Group, Inc.LTM Jun 20262.9% +0.9 pp+3.6 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-0.2% +8.0 pp+24.0 pp
HTFLHeartflow, Inc. Common StockLTM Sep 2026-30.2% +29.3 pp—
ZLABZai Lab LimitedLTM Jun 2026-37.5% +8.1 pp+167.8 pp
IRONDisc Medicine, Inc.FY2025— ——
Peer median (excluding PBH) 7.3%+8.0 pp+5.3 pp

Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.09B1.13B1.13B1.14B1.09B
Cost of Revenue466.17M502.43M500.91M503.3M514.07M
Gross Profit620.65M625.29M624.45M634.46M574.64M
Gross Margin57.1%55.4%55.5%55.8%52.8%
Research & Development00000
Selling, General & Admin264.8M252.42M259.47M263.93M265.23M
Operating Expenses290.73M647.71M282.02M297.69M265.23M
Depreciation & Amortization32.09M32.63M30.68M30.17M31.27M
EBITDA358.84M7.87M373.86M361.99M331.11M
EBITDA Margin33.0%0.7%33.2%31.8%30.4%
Operating Income329.92M(22.42M)342.43M336.78M309.41M
Operating Margin30.4%-2.0%30.4%29.6%28.4%
Interest Income00000
Interest Expense64.29M69.16M67.16M47.63M42.34M
Other Income / Expenses(67.46M)(71.5M)(66.4M)(52.59M)(51.91M)
Income Before Tax262.46M(93.92M)276.03M284.19M257.5M
Pre-Tax Margin24.1%-8.3%24.5%25.0%23.7%
Income Tax Expense57.08M(11.61M)66.69M69.58M67.2M
Net Income205.38M(82.31M)209.34M214.61M190.3M
Net Margin18.9%-7.3%18.6%18.9%17.5%
EPS (Basic)4.09(1.65)4.214.323.93
EPS (Diluted)4.04(1.65)4.174.293.91
Weighted Avg Shares50.26M49.88M49.76M49.7M48.46M
Weighted Avg Shares (Diluted)50.84M49.89M50.18M50.08M48.72M

Prestige Consumer Healthcare Inc.

NYSE:PBH

Intrinsic Alpha fair value

Locked

Current Price

$50.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.